guselkumab,risankizumab,adalimumab,ustekinumab
janssen,abbvie
['ibd']
 glad i had the chance to attend the final day of #acg2022 so that i could watch the mighty talk about il-12/il-23 receptor antagonists as exciting, innovative therapies within the #ibd algorithm! #gitwitter #ibdtwitter #ibd 
Internal Medicine PGY2 at University at Buffalo ?? @UBIMresidency | Aspiring gastroenterologist | @ChelseaFC ?? @Suns ?? | Chasing that #runnershigh ?????????